In Ohio, the fight against the coronavirus continues. Hospitals are seeing an increase in patients with COVID-19, with the state health department reporting that in the most recent week, an additional 124 individuals have been hospitalized due to the virus. This is a substantial increase from the 34 patients reported the week of June 6, and significantly higher than the 53 patients reported at the same point last year.
These numbers indicate that despite many individuals already having been infected and immunized, the virus continues to find ways to spread, particularly through newer, more elusive variants. One such case is the offspring of the Omicron variant, which has been responsible for a renewed surge in COVID-19 infections. Health experts caution that these new variants are more skilled at avoiding the protective barriers set up by previous infections and immunizations. An updated vaccine is in development and is set to be released this fall.
Still, questions remain about whether the new vaccine will be sufficient to curb the rise in hospitalizations and illness expected this winter, particularly if vaccination rates decline. To understand the nature of these new variants and their implications for public health, we turn to expert opinions from Dr. Hareesh Singam, an infectious disease specialist at the Cleveland Clinic, Dr. Amy Ray, MetroHealth Vice President of Infection Prevention and Epidemiology, and Dr. Amy Edwards, Associate Medical Director of Pediatric Infection Control at University Hospitals Rainbow Babies and Children’s Hospital.
According to these experts, the latest surge in COVID-19 cases and hospitalizations is primarily driven by emerging variants labeled KP.2 and KP.3, collectively referred to as the ‘FLiRT’ variants, and LB.1. These new strains have found wide circulation across the United States, with the KP.3 variant alone accounting for around 40 percent of the nation’s new COVID-19 infections.
Fortunately, despite the recent uptick in cases, the rate of new hospitalizations remains relatively low, underscoring the continued importance of vaccination in controlling severe disease outcomes. In conclusion, it is paramount to take the COVID-19 virus seriously, considering its propensity for continuous mutation and the resultant periodical spikes in cases, its capacity to evade existing immunity, and the potential for these new variants to spread more rapidly. As public health professionals, ongoing vigilance, education, and proactive measures in response to these evolving challenges are essential to keep infectious diseases under control.